We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Device Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Risk-Based Clinical Quality Assurance
Email
Tweet

Risk-Based Clinical Quality Assurance

Conference

Risk-Based Clinical Quality Assurance:
Train Your Auditors Like the FDA Does

Bethesda, MD • June 18-19, 2014

  • Event Home
  • Register
  • Agenda
  • Venue
  • Who Will Benefit
  • Speaker
  • FDAnews Home
● ● ●

Conference Details

Dates:

Wednesday-Thursday,
June 18-19, 2014

Where:

Marriott Bethesda North Hotel & Conference Center
Bethesda, MD


Click here to view
the Brochure.

This Event Has Been Cancelled.
For now, this conference is not being rescheduled,
but we will let you know if this changes.
Click here to see other upcoming conferences and webinars by FDAnews.

Risk-Based Clinical Quality Assurance
Train Your Auditors Like The FDA Does

 
New in 2014 — One-of-a-kind workshop teaches proven tips and tricks for training your auditors to spot even the slightest violations — before the FDA does.

In two action-packed days, you'll learn what FDA investigators use to evaluate your sites.  This interactive workshop will teach you how to develop risk-based CQA processes and compliance readiness.

You'll benefit from the first-hand knowledge and experience of workshop leader and expert Michelle Sceppa, a 25-year quality assurance and regulatory compliance veteran in both the pharmaceutical and medical device industries.

Some of the most common Form 483 citations issued to clinical sites include:

  • Failure to follow protocol — a clinical investigation was not conducted in accordance with the signed statement of the investigator
  • Case history reports that are inaccurate or inadequate
  • Failure to obtain consent forms — or the consent forms were not approved, signed or dated

 
Any one of these could derail your project, costing you millions in lost revenue.  On June 18-19 in Bethesda, MD, auditing veteran Michelle Sceppa walks you step by step through such details as:

  • A review of how FDA conducts clinical inspections and the top 5 GCP violations
  • How to write GCP audit SOPs — what elements to include
  • Writing a central laboratory audit SOP and why you need this SOP
  • Selecting sites to be audited — creating a master audit plan and how to make sure it is met
  • Audits of a central laboratory — why lab data and testing are a critical component of the clinical study
     

Throughout the workshop, you'll also participate in invaluable Interactive Exercises that will make you feel like you're engaged in an actual inspection, giving you priceless hands-on experience that will serve you well for years to come.

Identify the elements of and compose a central laboratory audit SOP … learn the 5 Key Tools for CQA Auditors: Preparation, Performance, Interviewing, Writing and Post-Assessment — and how to confidently employ them … and much, much more.

 
Finally, you'll walk away after two days with valuable tools you'll be able to put to use immediately:

  • Slides from PowerPoint presentations
  • Case review worksheets
  • Interactive exercise worksheets
  • SOPs, forms, templates for CQA audits: site, CRO and central laboratory
  • Copies of applicable FDA/ICH regulations and guidances

 
Clear your calendar NOW for Risk-Based Clinical Quality Assurance: Train Your Auditors Like the FDA Does on June 18-19, 2014, in Bethesda, MD.

Don't miss out on this unique opportunity to learn to confidently conduct comprehensive and effective CQA audits — and become the CQA expert at your company.

Sign up today.

 

footer info

Upcoming Events

  • 10Mar

    FDA Drug GMP Facility Inspections During the Pandemic

  • 16Mar

    Pharmaceutical Naming Regulation: Understanding the Latest Developments

  • 18Mar

    Pharmaceutical Postmarket Surveillance: Latest Developments in the Era of COVID-19

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 30Mar

    Data Integrity for GMP/Postmarket Professionals: Core Requirements, Expectations and Challenges

  • 06Apr

    Medical Device Cybersecurity: Understand the Latest Developments

Featured Products

  • Biological Risk Evaluation and Management for Medical Devices

  • GMP Inspection Preparation Checklist: A Tool for Internal Auditing

Featured Stories

  • AstraZeneca

    AstraZeneca Withdraws Imfinzi’s Bladder Cancer Indication

  • CE mark

    Cue Health’s COVID-19 Test Receives CE Mark

  • Sanofi-Regeneron_Logos.png

    Sanofi’s and Regeneron’s Libtayo Wins FDA Approval for NSCLC

  • PerkinElmer logo

    PerkinElmer’s Rapid Point-of-Care COVID-19 Test Cleared in Europe

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing